These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 742946)

  • 41. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
    Casali P; Lambert PH
    Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and characterization of subcomponent C1q of the first component of mouse complement.
    Yonemasu K; Sasaki T
    Biochem J; 1981 Feb; 193(2):621-9. PubMed ID: 7305948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decrease in molecular weight of cytoplasmic DNA polymerase on treatment with bromelain plus RNase and DNase.
    Shiosaka T; Aoki M; Fujii S
    J Biochem; 1974 Jun; 75(6):1399-401. PubMed ID: 4426901
    [No Abstract]   [Full Text] [Related]  

  • 45. C1q-binding substances in peripheral lymph in bronchial carcinoma.
    Heier HE; Sokolowski JA; Solheim OP
    Lymphology; 1978 Dec; 11(4):170-3. PubMed ID: 739789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subunit interactions in the first component of complement, C1.
    Lakatos S
    Biochem Biophys Res Commun; 1987 Dec; 149(2):378-84. PubMed ID: 2827640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of C1q in human sera.
    Rosano CL; Parhami N; Hurwitz C
    J Lab Clin Med; 1979 Oct; 94(4):593-9. PubMed ID: 113476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complement subcomponent C1q in various strains of mice. Its serum content correlates with that of immunoglobulin G.
    Yonemasu K; Sasaki T; Hashimoto H; Tsukao N
    Int Arch Allergy Appl Immunol; 1988; 86(1):97-101. PubMed ID: 3259550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demonstration and quantitation of activation of the first component of complement in human serum.
    Ziccardi RJ; Cooper NR
    J Exp Med; 1978 Feb; 147(2):385-95. PubMed ID: 75238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
    Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
    Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C1q deficiency associated with urticarial-like lesions and cutaneous vasculitis.
    Marder RJ; Rent R; Choi EY; Gewurz H
    Am J Med; 1976 Oct; 61(4):560-5. PubMed ID: 973650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.
    Svehag SE
    Scand J Immunol; 1975; 4(7):687-97. PubMed ID: 1198070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
    Bratt T; Ohlson S
    J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
    Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
    Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunologic study of pleural neoplastic effusions: Detection of immune complexes and complement activation].
    Kaelin R; Docquier C; Lew D; Carpentier N; Lambert PH; Waldvogel FA
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1971-3. PubMed ID: 749195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical correlates of C1Q-precipitating substances in the sera of patients with leprosy.
    Gelber RH; Drutz DJ; Epstein WV; Fasal P
    Am J Trop Med Hyg; 1974 May; 23(3):471-5. PubMed ID: 4823798
    [No Abstract]   [Full Text] [Related]  

  • 59. The cardiac auto-immune system.
    Halbert SP
    Int Arch Allergy Appl Immunol; 1971; 41(1):117-21. PubMed ID: 4997942
    [No Abstract]   [Full Text] [Related]  

  • 60. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
    Jacobs RJ; Mocharla R
    J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.